The surface expression of the mutants G57V, R280P, and E527D was significantly (P< 0

The surface expression of the mutants G57V, R280P, and E527D was significantly (P< 0.05) reduced by 30, 35, and 70%, respectively, compared with WT (Fig. CLC-5 mutations are heterogeneous and may be classified into three major groups and that a correlation between the nature of the defect and the location of the mutation in the structure may be drawn. This model may prove to be useful as a tool to aid in the analysis and future restorative intervention of the disease. Keywords:chloride channel, endocytosis, endosomal acidification, proteinuria dent's disease is an x-linkedrenal tubulopathy that is characterized by low molecular excess weight proteinuria, hypercalciuria, nephrocalcinosis/nephrolithiasis, and progressive renal failure (18,31,36). The disease is primarily associated with inactivating mutations in theCLCN5gene (Dent disease 1; OMIM 300009; Ref.18), although more recently it has also been reported to be due to mutations of theOCRL1gene that encodes a phosphatidylinositol-4,5-bisphosphate-5-phosphatase (Dent disease 2; OMIM 300555; Ref.13). It is generally thought that the principal cause of Dent's disease (31) results from a loss of practical CLC-5 from your subapical endosomes of kidney proximal tubule cells leading to a defect in endosomal acidification and impaired protein reabsorption (14,16). CLCN5encodes CLC-5, a voltage-dependent chloride/proton exchanger of the voltage-gated chloride channel (CLC) family (8,27,30). CLC-5 forms a dimer of two identical subunits, each of which contains a complete ion conduction pathway and is composed of 18 -helices (A-R). It is found abundantly in the nephron, particularly in the cells of the proximal tubule (5). The majority of CLC-5 is located in several subapical endosomes, with only a small portion present in the apical membrane ( 8%; Refs.5,10,32,38). Right function of these endosomes is vital to facilitate the endocytosis of low molecular excess weight proteins from the primary urine. In subapical endosomes, CLC-5 colocalizes with v-ATPase and is thought to contribute a Clconductance into the endosomal lumen to counterbalance the build up of H+due to the action of Mouse monoclonal to Ractopamine v-ATPase (10). Consistent with this, CLC-5 knockout (KO) mice show a reduced rate of endosomal acidification than that observed in wild-type (WT) mice (11). Dent’s disease results from missense MC-Val-Cit-PAB-clindamycin mutations in CLC-5 as well as nonsense mutations and foundation insertions/deletions that lead to MC-Val-Cit-PAB-clindamycin truncation of the protein (15,19,22,40). Previous investigations (17,18,21) focused on the impact of missense mutations around the function and cell surface targeting of CLC-5 heterologously expressed inXenopusoocytes. Consequently, there is little understanding of MC-Val-Cit-PAB-clindamycin how disease-causing mutations disrupt trafficking or the function of CLC-5 in membranes and organelles where they may play important physiological roles, for example, in endosomal acidification. To further elucidate the underlying causes of Dent’s disease, we investigated the functional and cell biological effects of known Dent’s disease mutations in a mammalian expression system and, through the use of molecular modeling, examined the relationship between the nature of the defects and the structure of the protein. == MATERIALS AND METHODS == == DNA constructs and cell lines. == Human CLC-5 was cloned into either pEYFP-N1 (Clontech) to be expressed with a fused C-terminal yellow fluorescent protein (CLC-5-YFP) or into pcDNA6 with an N-terminal HA tag (HA-CLC-5). Mutations were generated using the Quikchange site-directed mutagenesis protocol (Stratagene) and verified by DNA sequencing (University or college of Leeds Facility). Ratiometric pHluorin fused to either VAMP2 or GPI-anchor (24) was kindly donated by Dr. G. Miesenbck (Yale University or college). HEK-MSR cells were obtained from Invitrogen and were cultured in DMEM supplemented with MC-Val-Cit-PAB-clindamycin 10% (vol/vol) FBS. HEK-MSR cells stably expressing WT or mutant HA-CLC-5 were produced by transfection using Fugene 6 (Roche) followed by selection of positive transfectants with 5 g/ml blasticidin (Invitrogen). After selection, stably expressing cells were managed in medium supplemented with blasticidin and expression was confirmed by Western blotting. == Electrophysiology. == HEK-MSR cells were transiently transfected with CLC-5-YFP using Fugene 6. Transfected cells were recognized by YFP epifluorescence. Patch pipettes were pulled from thin-walled borosilicate glass (Harvard Apparatus) and polished. Electrode resistances ranged from 2 to 3 3 M in experimental solutions. Currents were recorded using the whole cell patch clamp configuration with an EPC-10 amplifier (HEKA Electronics) with >80% series resistance compensation where appropriate. Currents were filtered at 10 kHz and digitized at 50 kHz using PatchMaster software (HEKA Electronics). Cells were held at 30-mV and 10-ms pulses from 100 to +200 mV at 10-mV increments that were applied at 1-s intervals. P/4 leak subtraction was used. The bath answer contained the following (in.